TranscriptsNov. 04, 2025 7:26 PM ETCorcept Therapeutics Incorporated (CORT) StockCORTSA Transcripts156.42K FollowersCommentsCorcept Therapeutics Incorporated (CORT) Q3 2025 Earnings Call November 4, 2025 5:00 PM ESTCompany ParticipantsAtabak Mokari - CFO & TreasurerGary Robb - Chief Business Officer & SecretarySean Maduck - President of EndocrinologyJoseph K. Belanoff - Co-Founder, President, CEO & DirectorWilliam Guyer - Chief Development OfficerConference Call ParticipantsEdward Nash - Canaccord Genuity Corp., Research DivisionDavid Amsellem - Piper Sandler & Co., Research DivisionAsim Rana - Truist Securities, Inc., Research DivisionSwayampakula Ramakanth - H.C. Wainwright & Co, LLC, Research DivisionPresentationOperatorThank you for standing by, and welcome to Corcept Therapeutics Third Quarter 2025 Earnings Conference Call. [Operator Instructions]I would now like to hand the call over to Atabak Mokari, CFO. Please go ahead.Atabak MokariCFO & TreasurerHello, everyone. Good afternoon, and thank you for joining us. Today, we issued a press release announcing our financial results for the third quarter and providing a corporate update. A copy is available at corcept.com. Our complete financial results will be available when we file our Form 10-Q with the SEC. Today's call is being recorded. A replay will be available at the Investors Past Events tab of our website. We will also post a presentation regarding our oncology development programs in the same section.Statements during this call other than statements of historical fact are forward-looking statements based on our plans and expectations that are subject to risks and uncertainties, which might cause actual results to be materially different from those such statements expressed or implied. The risks and uncertainties that may affect our forward-looking statements are described in our annual report on Form 10-K and our quarterly reports on Form 10-Q, all of which are available at the SEC's website. Please refer to those documents for additional information. We disclaim any intention or duty to update forward-looking statements.Read more current CORT analysis and newsView all earnings call transcriptsCommentsRecommended For You